Tiverton Asset Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-6,446
| Closed | -$201K | – | 755 |
|
|
2019
Q2 | $201K | Hold |
6,446
| – | – | 0.01% | 558 |
|
|
2019
Q1 | $151K | Hold |
6,446
| – | – | 0.01% | 545 |
|
|
2018
Q4 | $89K | Sell |
6,446
-15,188
| -70% | -$210K | 0.01% | 387 |
|
|
2018
Q3 | $216K | Buy |
21,634
+13,595
| +169% | +$136K | 0.01% | 320 |
|
|
2018
Q2 | $163K | Buy |
+8,039
| New | +$163K | 0.01% | 336 |
|